Greenleaf Trust Invests $217,000 in Universal Health Services, Inc. (NYSE:UHS)

Greenleaf Trust bought a new position in shares of Universal Health Services, Inc. (NYSE:UHSFree Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 1,425 shares of the health services provider’s stock, valued at approximately $217,000.

Several other institutional investors also recently modified their holdings of UHS. EverSource Wealth Advisors LLC grew its position in shares of Universal Health Services by 42.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 267 shares of the health services provider’s stock worth $34,000 after buying an additional 80 shares during the period. Platinum Investment Management Ltd. grew its position in shares of Universal Health Services by 16.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 727 shares of the health services provider’s stock worth $91,000 after buying an additional 105 shares during the period. Tompkins Financial Corp acquired a new position in shares of Universal Health Services during the 4th quarter worth about $96,000. Van ECK Associates Corp grew its position in shares of Universal Health Services by 9.6% during the 3rd quarter. Van ECK Associates Corp now owns 1,004 shares of the health services provider’s stock worth $126,000 after buying an additional 88 shares during the period. Finally, V Square Quantitative Management LLC acquired a new position in shares of Universal Health Services during the 3rd quarter worth about $175,000. 86.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Universal Health Services

In other news, CFO Steve Filton sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $176.82, for a total transaction of $6,188,700.00. Following the sale, the chief financial officer now owns 68,785 shares in the company, valued at approximately $12,162,563.70. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 16.10% of the company’s stock.

Wall Street Analysts Forecast Growth

UHS has been the subject of several analyst reports. Citigroup boosted their target price on Universal Health Services from $170.00 to $193.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th. The Goldman Sachs Group boosted their price objective on Universal Health Services from $170.00 to $189.00 and gave the company a “buy” rating in a research report on Monday, March 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on Universal Health Services from $208.00 to $203.00 and set a “buy” rating for the company in a research report on Friday, April 12th. UBS Group boosted their price objective on Universal Health Services from $152.00 to $177.00 and gave the company a “neutral” rating in a research report on Thursday, February 29th. Finally, Barclays started coverage on Universal Health Services in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $181.00 price objective for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $179.71.

View Our Latest Stock Report on Universal Health Services

Universal Health Services Trading Up 0.6 %

NYSE UHS opened at $165.84 on Thursday. The stock has a market capitalization of $11.15 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 0.82 and a beta of 1.24. The stock’s 50 day moving average price is $170.50 and its two-hundred day moving average price is $153.01. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.29 and a current ratio of 1.40. Universal Health Services, Inc. has a 52 week low of $119.90 and a 52 week high of $183.61.

Universal Health Services (NYSE:UHSGet Free Report) last released its earnings results on Wednesday, April 24th. The health services provider reported $3.70 EPS for the quarter, beating the consensus estimate of $3.12 by $0.58. The firm had revenue of $3.84 billion for the quarter, compared to analysts’ expectations of $3.78 billion. Universal Health Services had a return on equity of 12.08% and a net margin of 5.03%. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.34 EPS. As a group, analysts anticipate that Universal Health Services, Inc. will post 13.34 earnings per share for the current fiscal year.

About Universal Health Services

(Free Report)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Read More

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHSFree Report).

Institutional Ownership by Quarter for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.